# Luiz Noronha

> Luiz Noronha is a Series A investor at DNA Capital (São Paulo) backing Health Care and Medical. See 11 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [DNA Capital](https://shizune.co/investors/profile/dna-capital)
- Location: São Paulo, Brazil
- Total investments: 11
- Last investment: May 2026
- Lead investor: 55%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/luizhenriquenoronha/

Luiz Noronha is a Series A investor at DNA Capital in São Paulo focused on Health Care and Medical. Luiz Henrique Noronha is a partner at DNA Capital, running its VC practice. He is also an active angel investor.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 5 | 45% |
| Medical | 3 | 27% |
| Software | 2 | 18% |
| InsurTech | 2 | 18% |
| Health Insurance | 2 | 18% |

15 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 3 | 27% |
| Series B | 2 | 18% |
| Funding Round | 2 | 18% |
| Seed | 1 | 9% |
| Series C | 1 | 9% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Brazil | 5 | 45% |
| China | 1 | 9% |
| Hong Kong | 1 | 9% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Memed | The safest and friendliest e-prescribing tool, for doctors. The most convenient and affordable way for treatment adherence, for patients. | $15.9M |  | May 21, 2026 |  |
| Sanar | Sanar seeks to reshape future doctors and healthcare professionals to be much more efficient and assertive. We started the company as a knowledge platform; from the first moment they step into college, we follow the evolution of the professional throughout their career. Today, Sanar has become a platform for doctors entire lives, offering solutionsfor different stages of their journey: 1 - For students we offer SanarFlix; the platform has a multitude of content from the best teachers in the country and is helping the students to overcome the challenges they face in college. 2 - For the period of admission to medical residency, Sanar offers Sanar Medical Residency, a platform for test preparation to help doctors to enter the best programs in Brazil. 3 - For the general physician, we offer SanarYellow, a clinical decision-making tool with the most up-to-date guidelines, protocols, and drug interactions for point-of-care. 4 - Sanar is also helping to unlock the doctor's potential with SanarUp, a credit product which offers additional income for the most difficult phases of their professional career. |  | Debt Financing | May 25, 2022 |  |
| Memed | The safest and friendliest e-prescribing tool, for doctors. The most convenient and affordable way for treatment adherence, for patients. | $17.7M | Series C | Oct 29, 2021 |  |
| Memed | The safest and friendliest e-prescribing tool, for doctors. The most convenient and affordable way for treatment adherence, for patients. | $59.3M | Series C | Jun 16, 2021 |  |
| Beep Saúde | Application that lets you find high quality healthcare services where you need. | $2M | Series A | May 01, 2020 |  |
| Sanar | Sanar seeks to reshape future doctors and healthcare professionals to be much more efficient and assertive. We started the company as a knowledge platform; from the first moment they step into college, we follow the evolution of the professional throughout their career. Today, Sanar has become a platform for doctors entire lives, offering solutionsfor different stages of their journey: 1 - For students we offer SanarFlix; the platform has a multitude of content from the best teachers in the country and is helping the students to overcome the challenges they face in college. 2 - For the period of admission to medical residency, Sanar offers Sanar Medical Residency, a platform for test preparation to help doctors to enter the best programs in Brazil. 3 - For the general physician, we offer SanarYellow, a clinical decision-making tool with the most up-to-date guidelines, protocols, and drug interactions for point-of-care. 4 - Sanar is also helping to unlock the doctor's potential with SanarUp, a credit product which offers additional income for the most difficult phases of their professional career. | $11.5M | Series B | Apr 15, 2020 |  |
| Memed | The safest and friendliest e-prescribing tool, for doctors. The most convenient and affordable way for treatment adherence, for patients. | $4.6M | Series B | Feb 21, 2020 |  |
| The CareVoice | The CareVoice is a Shanghai-based international company established in 2014, backed by top VC, Asian and Chinese healthcare investors. It is a health InsurTech company transforming healthcare experience to be more consumer-centric. They bring unique mobile-based and data-driven solutions that digitalize healthcare and insurance journey withconsumers' interest first. | $10M | Series A | Aug 22, 2019 |  |
| blüüm | Blüüm is a health platform that offers augmented health services maximizing the quality of life at every stage. It enables users to enjoy a seamless health insurance journey all within the App such as a 24/7 virtual symptom checker, online clinic search, and appointment from an extensive medical network. Blüüm provides premium group medicalinsurance solutions at ‘affordable’ prices to startups and SMEs with complimentary employee benefits packages to support teams with different wellbeing and health needs. Currently, blüüm offers two insurance series which are tailored for sport lovers and SMEs, namely blüüm sport and blüüm team. |  | Seed | Jul 16, 2019 |  |
| Nuria | CM is changing the way the healthcare ecosystem connect and interact. We built the first online patients digital journey all integrated in the providers ERPs. Now we are not only connecting our modules but the entire market. We built a revolutionary integration platform to connect providers to any other health player, like insurance companies,health techs, distributor, pharma industry and more.We have became the healthcare gateway connecting more than 2.000 providers, generating more than 50MM transactions per year, and impacting millions of patients. | $5M | Series A | Jun 01, 2018 |  |

10 of 11 investments shown.

## Co-investors
- [Valor Capital Group](https://shizune.co/investors/profile/valor-capital) — VC Fund, 3 deals together
- [Vox Capital](https://shizune.co/investors/profile/vox-capital-llc) — VC Fund, 2 deals together
- [Artesian VC](https://shizune.co/investors/profile/artesian-capital-management) — VC Fund, 1 deal together
- [Banco Bradesco](https://shizune.co/investors/profile/banco-bradesco) — VC Fund, 1 deal together
- [Bridge One](https://shizune.co/investors/profile/bridge-one) — VC Fund, 1 deal together
- [Chinaccelerator](https://shizune.co/investors/profile/chinaccelerator) — VC Fund, 1 deal together

## About DNA Capital

VC Fund · São Paulo, Brazil

DNA Capital is an investment partnership specializing in multi-stage investments in the healthcare sector.

5 contacts available at DNA Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Carlos de Barros Jorge Neto | Partner | https://shizune.co/investors/profile/carlos-de-barros-jorge-neto |
| José Guinle | Partner | https://shizune.co/investors/profile/jos%C3%A9-eduardo-ribeiro-guinle |
| Luiz Felipe D Martins Costa | Managing Partner | https://shizune.co/investors/profile/luiz-felipe-d-martins-costa |
| Luiz Noronha | Partner | https://shizune.co/investors/profile/luiz-henrique-noronha |
| Mario Sergio Ribeiro | Partner | https://shizune.co/investors/profile/mario-sergio-ribeiro |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Luiz Noronha invest in?

Luiz Noronha invests primarily in Health Care, Medical and Software startups, most often at Series A and Series B stage. Most of the 11 investments tracked by Shizune back companies in Brazil. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Luiz Noronha last invest?

The most recent investment recorded for Luiz Noronha closed in May 2026. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co